BackPharmicell , Ltd. Overview

Pharmicell , Ltd. Profit Margin

Latest profit margin for Pharmicell , Ltd.: 31.3% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

22.42%
↓ 34.48% YoY

As of Sep 2026

Annual Profit Margin (TTM)

31.30%
↑ 9.77% YoY

Trailing 12 months ending Sep 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Pharmicell , Ltd. (005690.KS) FAQ

Pharmicell , Ltd.'s profit margin stands at 31.3% as of September 2026. That compares with 28.51% in the prior-year period — up 9.8% year over year. That is above the Healthcare sector average of 17.63%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Pharmicell , Ltd. reported 31.3% in profit margin versus 28.51% a year earlier — a 9.8% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

Pharmicell , Ltd. sits higher the Healthcare benchmark (17.63%) with a profit margin of 31.3%. That is roughly 77.5% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of 31.3% for Pharmicell , Ltd. means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Pharmicell , Ltd.'s profit margin evolved across reporting periods, while the comparison chart places 005690.KS next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.